<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04069806</url>
  </required_header>
  <id_info>
    <org_study_id>PUM_08.08.2019</org_study_id>
    <nct_id>NCT04069806</nct_id>
  </id_info>
  <brief_title>Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section</brief_title>
  <acronym>POC-NaVoP</acronym>
  <official_title>An Analysis of Risk Factors and Implementation of Strategies to Prevent Nausea and Vomiting in Patients Undergoing Regional Anesthesia for Caesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pomeranian Medical University Szczecin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pomeranian Medical University Szczecin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-operative nausea and vomiting (PONV) in women undergoing subarachnoid anesthesia for&#xD;
      Caesarean section is an important clinical problem. The aim of this study is to compare the&#xD;
      effectiveness of oral carbohydrate loading to standard pre-operative fasting in patients&#xD;
      undergoing elective cesarean section on the incidence and severity of PONV and biochemical&#xD;
      parameters indicating ketosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative nausea and vomiting (PONV) in women undergoing subarachnoid anesthesia for&#xD;
      Caesarean section is an important clinical problem. Known mechanisms underlying PONV are&#xD;
      based on prolonged fasting, hypotension due to concomitant sympatholysis during anesthesia,&#xD;
      bradycardia due to increased vagal tone, visceral stimulation during surgery and intrathecal&#xD;
      administered opioids. However, the identification of patients exposed to this problem and&#xD;
      appropriate perioperative preparation is of key importance. An analysis of risk factors for&#xD;
      postoperative nausea and vomiting in patients undergoing elective cesarean section under&#xD;
      spinal anesthesia is of major clinical importance. The aim of this study is a comparison of&#xD;
      the effectiveness of oral carbohydrate loading strategy as compared with standard&#xD;
      pre-operative fasting in patients undergoing elective cesarean section under spinal&#xD;
      anesthesia on the incidence and severity of PONV and biochemical parameters indicating&#xD;
      ketosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 3, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative nausea and vomiting 6 hours after caesarian section.</measure>
    <time_frame>6 hours</time_frame>
    <description>The Postoperative Nausea and Vomiting (PONV) Intensity Scale 6 hours after caesarian section. Scale range: 0-50. The scale measures PONV intensity, where a score ≥50 defined clinically important PONV: PONV Intensity Scale=severity of nausea (1=mild, 2=moderate, 3=severe)×pattern of nausea (1=varying, 2=constant)×duration of nausea (in hours).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative nausea and vomiting 24 hours after caesarian section.</measure>
    <time_frame>24 hours</time_frame>
    <description>The Postoperative Nausea and Vomiting (PONV) Intensity Scale 24 hours after caesarian section. Scale range: 0-50. The scale measures PONV intensity, where a score ≥50 defined clinically important PONV: PONV Intensity Scale=severity of nausea (1=mild, 2=moderate, 3=severe)×pattern of nausea (1=varying, 2=constant)×duration of nausea (in hours).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first peristalsis.</measure>
    <time_frame>24 hours</time_frame>
    <description>Moment of first peristalsis after operation (in hours).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first bowel movement.</measure>
    <time_frame>24 hours</time_frame>
    <description>Moment of first bowel movement after operation (in hours).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of serum lactate in serum.</measure>
    <time_frame>0 hours</time_frame>
    <description>Lactate level measured in maternal serum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of beta-hydroxy-butiric acid in serum.</measure>
    <time_frame>0 hours</time_frame>
    <description>Beta-hydroxy-butiric acid level measured in maternal serum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance factor (HOMA-IR).</measure>
    <time_frame>0 hours</time_frame>
    <description>Insulin resistance measured in maternal serum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of isoprostane in urine.</measure>
    <time_frame>0 hours</time_frame>
    <description>Isoprostane level measured in maternal urine.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Preoperative oral carbohydrate load</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 hours for solid food and 2 hours for liquids + oral carbohydrate preparation 2 hours prior to surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard preoperative fasting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>6 hours for solid food and 2 hours for liquids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>preoperative oral carbohydrate, preOp</intervention_name>
    <description>Patients in the experimental arm will receive oral carbohydrate preparation at 2 hours prior to planned caesarian section.</description>
    <arm_group_label>Preoperative oral carbohydrate load</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt;=18 years.&#xD;
&#xD;
          2. Scheduled for an elective cesarean section.&#xD;
&#xD;
          3. Uncomplicated pregnancy.&#xD;
&#xD;
          4. Planned for spinal anesthesia.&#xD;
&#xD;
          5. ASA I or ASA II.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of diabetes.&#xD;
&#xD;
          2. History of gastro-intestinal reflux (GERD).&#xD;
&#xD;
          3. Unable or unwilling to sign an informed consent.&#xD;
&#xD;
          4. Contraindications to spinal anesthesia.&#xD;
&#xD;
          5. Contraindication to Oral carbohydrate formula.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant patients scheduled for planned cesarian section.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katarzyna L Kotfis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pomeranian Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sebastian Kwiatkowski, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Pomeranian Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katarzyna L Kotfis, MD, PhD</last_name>
    <phone>0048914661144</phone>
    <email>katarzyna.kotfis@pum.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arleta Wojciechowska, RN</last_name>
    <email>arletawoj@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pomeranian Medical University</name>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna L Kotfis, MD</last_name>
      <phone>0048914661144</phone>
      <email>katarzyna.kotfis@pum.edu.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pomeranian Medical University Szczecin</investigator_affiliation>
    <investigator_full_name>Katarzyna Kotfis</investigator_full_name>
    <investigator_title>Primary Investigator</investigator_title>
  </responsible_party>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <keyword>Oral carbohydrate</keyword>
  <keyword>Fasting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

